Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering
Source abstract
Abstract
Various research groups around the world are actively investigating cardiovascular prostheses of biological origin. This review article discusses the need for such bioprosthetics and the potential role for natural tissues in cardiovascular applications such as cardiac valves and vascular grafts. Upon implantation, unmodified natural materials are subject to chemical and enzymatic degradation, seriously decreasing the life of the prosthesis. Therefore, methods such as glutaraldehyde and polyepoxide crosslinking treatments and dye-mediated photooxidation have been developed to stabilize the tissue while attempting to maintain its natural mechanical properties. Also, residual cellular components in a bioprosthetic material have been associated with undesired effects, such as calcification and immunological recognition, and thus have been the motivation for various decellularization processes. The effects of these stabilization and decellularization treatments on mechanical, biological and chemical properties of treated tissues have been investigated, specifically with regard to calcification, immunogenicity, and cytotoxicity concerns. Despite significant advances in the area of cardiovascular prostheses, there has yet to be developed a completely biocompatible, long-lasting implant. However, with the recent advent of tissue engineering, the possibility of applying selective cell seeding to naturally derived bioprosthetics moves us closer to a living tissue replacement.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Yoganathan AP. Cardiac valve prostheses. In: Bronzino JD, editor. The biomedical engineering handbook. Boca Raton, FL: CRC Press, 1995. p. 1847–70.
2. Black K. Successful trans-species implant of a tissue engineered heart valve. First International Symposium, Tissue Engineering for Heart Valve Bioprostheses, London, England, June 11, 1999.
3. Allograft valves for aortic and mitral valve replacement10.1097/00001573-199703000-00005 ↗
4. Tissue heart valves10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.3.CO;2-F ↗
5. The porcine bioprosthetic valve. Twelve years later10.1016/S0022-5223(19)38753-7 ↗
6. Early and late risk of mitral valve replacement. A 12 year concomitant comparison of the porcine bioprosthetic and prosthetic disc mitral valves10.1016/S0022-5223(19)38512-5 ↗
7. Ku DN, Allen RC. Vascular grafts. In: Bronzino JD, editor. The biomedical engineering handbook. Boca Raton, FL; CRC Press, 1995. p. 1985–96.
8. Conduit options in coronary artery bypass surgery10.1378/chest.108.4.1150 ↗
9. Barner HB. Arterial grafting: techniques and conduits. Ann Thorac Surg 1998;66(Suppl 5):S2–5; discussion S25–8.10.1016/S0003-4975(98)00966-7 ↗
10. Radial artery in CABG10.1016/S0003-4975(99)00223-4 ↗
11. Cryopreserved allograft veins as alternative coronary artery bypass conduits10.1016/0003-4975(92)90632-E ↗
12. Cryopreservation of veins as an alternative to autografts in coronary by-pass grafting
13. Small caliber vascular grafts. Part I. State of the art10.1177/088532829601000402 ↗
14. Hilbert SL, Ferrans VJ, Jones M. Tissue-derived biomaterials and their use in cardiovascular prosthetic devices. Med Prog Technol 1988–89;14:115–63.
15. Biological factors affecting long-term results of valvular heterografts10.1016/S0022-5223(19)42561-0 ↗
16. Yannas IV, Natural materials. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editor. Biomaterial science, San Diego: Academic Press, 1996. p. 84–94.
17. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses
18. Chemically modified collagen10.1002/jbm.820210606 ↗
19. Glutaraldehyde detoxification of aortic wall tissue
20. Reduction of calcification by various treatments in cardiac valves10.1177/088532829901300305 ↗
21. The inactivation of viruses by germicides
22. Immunological reactivity to a new glutaraldehyde tanned bovine pericardial heart valve
23. Immunological involvement in porcine bioprosthetic valve degeneration
24. Immunogenicity of glutaraldehyde-tanned bovine pericardium10.1016/S0022-5223(20)31465-3 ↗
25. Extracellular matrix proteins
26. Trowbridge EA, Lawford PV, Crofts CE, Roberts KM. Pericardial heterografts: why do these valves fail? J Thorac Cardiovasc Surg 1988;95:577–85.10.1016/S0022-5223(19)35721-6 ↗
27. An assessment of the mechanical properties of leaflets from four second-generation porcine bioprostheses with biaxial testing techniques10.1016/S0022-5223(19)34407-1 ↗
28. Glutaraldehyde fixation alters the internal shear properties of porcine aortic heart valve tissue10.1016/0003-4975(95)00250-O ↗
29. The standardisation of gauge length10.1016/0021-9290(86)90119-3 ↗
30. The bovine pericardial xenograft10.1002/jbm.820230502 ↗
31. Tissue buckling as a mechanism of bioprosthetic valve failure10.1016/S0003-4975(10)65930-9 ↗
32. Influence of fixation conditions on the performance of glutaraldehyde-treated porcine aortic valves10.1136/thx.34.2.166 ↗
33. The physical properties of bovine pericardium10.1016/S0003-4975(10)60789-8 ↗
34. The bovine pericardial xenograft10.1002/jbm.820230503 ↗
35. The bovine pericardial xenograft10.1002/jbm.820230504 ↗
36. Effect of applied uniaxial stress on rate and mechanical effects of cross-linking in tissue-derived biomaterials10.1016/0142-9612(95)00305-3 ↗
37. Biaxial mechanical/structural effects of equibiaxial strain during crosslinking of bovine pericardial xenograft materials10.1016/S0142-9612(98)00142-2 ↗
38. Elastic and viscoelastic material behaviour of fresh and glutaraldehyde-treated porcine aortic valve tissue10.1016/0021-9290(83)90017-9 ↗
39. Solvent environment modulates effects of glutaraldehyde crosslinking on tissue-derived biomaterials10.1002/(SICI)1097-4636(199608)31:4<533::AID-JBM14>3.0.CO;2-H ↗
40. Altered mechanical properties in aortic elastic tissue using glutaraldehyde/solvent solutions of various dielectric constant10.1002/(SICI)1097-4636(19971215)37:4<497::AID-JBM8>3.0.CO;2-G ↗
41. Toxic reactions evoked by glutaraldehyde-fixed pericardium and cardiac valve tissue bioprosthesis10.1002/jbm.820180703 ↗
42. Toxic effects of aldehydes released from fixed pericardium on bovine aortic endothelial cells10.1002/jbm.820231111 ↗
43. Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials10.1002/jbm.820140607 ↗
44. Weadock K, Olson RM, Silver FH. Evaluation of collagen crosslinking techniques. Biomater Med Dev Artif Organs 1983–84;11:293–318.10.3109/10731198309118815 ↗
45. Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived crosslinks10.1002/jbm.820240905 ↗
46. Improved biocompatibility of bioprosthetic heart valves by L-glutamic acid treatment
47. In vitro and in vivo endothelialization of glutaraldehyde treated bovine pericardium
48. Decreased tissue reaction to bioprosthetic heart valve material after L-glutamic acid treatment. A morphological study10.1002/jbm.820260912 ↗
49. Prevention of bioprosthetic heart valve tissue calcification by charge modification10.1002/jbm.820250107 ↗
50. Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate10.1126/science.3919445 ↗
51. Detoxification process for glutaraldehyde-treated bovine pericardium
52. Biocompatibility of aldehyde-fixed bovine pericardium. An in vitro and in vivo approach toward improvement of bioprosthetic heart valves10.1016/S0022-5223(19)36551-1 ↗
53. Calcification of pericardial tissue pretreated with different amino acids10.1016/0142-9612(96)88707-2 ↗
54. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material10.1016/S0003-4975(96)00442-0 ↗
55. In vitro and in vivo calcification of vascular bioprostheses10.1016/S0142-9612(98)00038-6 ↗
56. Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments
57. Chemical assay of glutaraldehyde incorporation into pericardial tissue
58. High glutaraldehyde concentrations reduce rather than increase the calcification of aortic wall tissue
59. Aldehyde tanning10.1016/1010-7940(91)90037-K ↗
60. The role of material surface chemistry in implant device calcification
61. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization
62. Role of mechanical stress in calcification of aortic bioprosthetic valves10.1016/S0022-5223(19)39217-7 ↗
63. Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress10.1016/0002-9149(86)90067-6 ↗
64. Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure
65. Phosphatase enzyme activity is retained in glutaraldehyde treated bioprosthetic heart valves
66. Calcification of soft tissue employed in the construction of heart valve prostheses10.1016/0142-9612(91)90208-R ↗
67. Study of the calcification of bovine pericardium10.1016/0142-9612(91)90117-S ↗
68. Development of a pericardial acellular matrix biomaterial10.1002/jbm.820280602 ↗
69. Al3 binding studies and metallic cation effects on bioprosthetic heart valve calcification in the rat subdermal model10.1097/00002480-199004000-00003 ↗
70. Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole10.1016/0142-9612(90)90034-N ↗
71. Experimental study on modified treatment and endothelialization of bovine pericardial valves10.1007/BF02888287 ↗
72. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves10.1161/01.CIR.90.1.323 ↗
73. Biomaterial-associated calcification
74. Initiation of mineralization in bioprosthetic heart valves10.1002/jbm.820250802 ↗
75. Lipid extraction attenuates the calcific degeneration of bovine pericardium used in cardiac valve bioprostheses
76. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms10.1161/01.CIR.95.2.479 ↗
77. Vyavahare NR, Hirsch D, Lerner E et al. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res 1998 15;40:577–85.10.1002/(SICI)1097-4636(19980615)40:4<577::AID-JBM9>3.0.CO;2-C ↗
78. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P ↗
79. Laboratory evaluation of tissue heart valves. A comparative assessment
80. Biological vascular grafts
81. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb10.1067/mva.1988.avs0070336 ↗
82. The second decade of experience with the umbilical vein graft for lower-limb revascularization10.1016/0967-2109(95)93874-O ↗
83. History of prosthetic grafts
84. Revascularization of the femoropopliteal arteries using saphenous vein, polytetrafluoroethylene, and umbilical vein grafts. Five- and six-year results10.1001/archsurg.1982.01380360019005 ↗
85. A randomized clinical trial of PTFE versus human umbilical vein for femoropopliteal bypass surgery. Preliminary results10.1002/bjs.1800700210 ↗
86. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices10.1016/0142-9612(96)82721-9 ↗
87. Cell and tissue fixation, 1972–198210.1007/BF01003203 ↗
88. Effect of alternative crosslinking methods on the low strain rate viscoelastic properties of bovine pericardial bioprosthetic material10.1002/jbm.820240307 ↗
89. Amide cross-linking
90. Chemical modification of implantable biologic tissue for anti-calcification10.1097/00002480-199407000-00026 ↗
91. Application of a vascular graft material (Solcograft-P) in experimental surgery10.1016/0142-9612(85)90086-9 ↗
92. Early complications with a new bovine arterial graft (Solcograft-P)
93. Longterm study of a compliant biological vascular graft10.1016/S0950-821X(05)80680-2 ↗
94. HMDC crosslinking of bovine pericardial tissue10.1007/BF00146862 ↗
95. Structural changes in implanted cardiac valvular bioprostheses constructed of glycerol-treated human dura mater10.1016/1010-7940(91)90213-4 ↗
96. Hoffman D, Gong G, Liao K, Macaluso F, Nikolic SD, Frater RW. Spontaneous host endothelial growth on bioprostheses. Influence of fixation. Circulation 1992;86(Suppl 5):II75–9
97. Thermal cross-linking for biologically degradable materials. Preliminary report10.1097/00002480-199609000-00115 ↗
98. Epoxy compounds as a new cross-linking agent for porcine aortic leaflets
99. Effect of pretreatment with epoxy compounds on the mechanical properties of bovine pericardial bioprosthetic materials10.1177/088532829200700104 ↗
100. Prevention of tissue calcification on bioprosthetic heart valve by using epoxy compounds10.1002/jbm.820260913 ↗